Improved protection against disseminated tuberculosis by Mycobacterium bovis bacillus Calmette-Guérin secreting murine GM-CSF is associated with expansion and activation of APCs

Journal of Immunology

Volumn 179, Issue 12, 2007, Pages 8418-8424

  Ryan, Anthony A ^a   Wozniak, Teresa M ^a   Shklovskaya, Elena ^a   O'Donnell, Michael A ^b   De St Groth, Barbara Fazekas ^a   Britton, Warwick J ^a   Triccas, James A ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CD11B ANTIGEN; GAMMA INTERFERON; GLYCOPROTEIN P 15095; INTERLEUKIN 12; MAJOR HISTOCOMPATIBILITY ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ARTICLE; BACILLUS; BACTERIAL STRAIN; BCG VACCINATION; C57BL 6 MOUSE; CELL COUNT; CELL DIFFERENTIATION; CELL EXPANSION; CELL FUNCTION; CELL MIGRATION; CELL STIMULATION; CELL SUSPENSION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; FEMALE; HEMATOPOIETIC STEM CELL; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOSTIMULATION; IN VITRO STUDY; LYMPH NODE; LYMPHATIC DRAINAGE; MALE; MILIARY TUBERCULOSIS; MOUSE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRECURSOR; PRIORITY JOURNAL; SECRETORY CELL; SPLEEN; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VACCINATION; ANIMAL; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE STRAIN; TUBERCULOSIS;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD11B; ANTIGENS, CD11C; BCG VACCINE; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED STRAINS; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; T-LYMPHOCYTES; TUBERCULOSIS;

EID: 40049100093     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.12.8418     Document Type: Article

References (49)

1. Bhatt, K., S. P. Hickman, and P. Salgame. 2004. Cutting edge: a new approach to modeling early lung immunity in murine tuberculosis. J. Immunol. 172: 2748-2751.
2. Flynn, J. L., and J. Chan. 2001. Immunology of tuberculosis. Ann. Rev. Immunol. 19: 93-129.
3. Hickman, S. P., J. Chan, and P. Salgame. 2002. Mycobacterium tuberculosis induces differential cytokine production from dendritic cells and macrophages with divergent effects on naive T cell polarization. J. Immunol. 168: 4636-4642.
4. Cooper, A. M., D. K. Dalton, T. A. Stewart, J. P. Griffin, D. G. Russell, and I. M. Orme. 1993. Disseminated tuberculosis in interferon γ gene-disrupted mice. J. Exp. Med. 178: 2243-2247.
5. Hart, D. N. 1997. Dendritic cells: unique leukocyte populations which control the primary immune response. Blood 90: 3245-3287.
6. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252.
7. Shortman, K., and Y. J. Liu. 2002. Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2: 151-161.
8. Jiao, X., R. Lo-Man, P. Guermonprez, L. Fiette, E. Deriaud, S. Burgaud, B. Gicquel, N. Winter, and C. Leclerc. 2002. Dendritic cells are host cells for mycobacteria in vivo that trigger innate and acquired immunity. J. Immunol. 168: 1294-1301.
9. + T cell response to Mycobacterium tuberculosis and exacerbates the outcome of infection. J. Immunol. 175: 3268-3272.
10. Leemans, J. C., T. Thepen, S. Weijer, S. Florquin, N. van Rooijen, J. G. van de Winkel, and T. van der Poll. 2005. Macrophages play a dual role during pulmonary tuberculosis in mice. J. Infect. Dis. 191: 65-74.
11. Gasson, J. C. 1991. Molecular physiology of granulocyte-macrophage colony-stimulating factor. Blood 77: 1131-1145.
12. Shi, Y., C. H. Liu, A. I. Roberts, J. Das, G. Xu, G. Ren, Y. Zhang, L. Zhang, Z. R. Yuan, H. S. Tan, et al. 2006. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and T-cell responses: what we do and don't know. Cell Res. 16: 126-133.
13. Larsen, C. P., S. C. Ritchie, R. Hendrix, P. S. Linsley, K. S. Hathcock, R. J. Hodes, R. P. Lowry, and T. C. Pearson. 1994. Regulation of immunostimulatory function and costimulatory molecule (B7-1 and B7-2) expression on murine dendritic cells. J. Immunol. 152: 5208-5219.
14. Burger, J. A., S. M. Baird, H. C. Powell, S. Sharma, D. J. Eling, and T. J. Kipps. 2000. Local and systemic effects after adenoviral transfer of the murine granulocyte-macrophage colony-stimulating factor gene into mice. Br. J. Haematol. 108: 641-652.
15. high murine dendritic cells in vivo: a comparative analysis with Flt3 ligand. J. Immunol. 165: 49-58.
16. Daro, E., E. Butz, J. Smith, M. Teepe, C. R. Maliszewski, and H. J. McKenna. 2002. Comparison of the functional properties of murine dendritic cells generated in vivo with Flt3 ligand, GM-CSF and Flt3 ligand plus GM-SCF. Cytokine 17: 119-130.
17. Miller, G., V. G. Pillarisetty, A. B. Shah, S. Lahrs, Z. Xing, and R. P. DeMatteo. 2002. Endogenous granulocyte-macrophage colony-stimulating factor overexpression in vivo results in the long-term recruitment of a distinct dendritic cell population with enhanced immunostimulatory function. J. Immunol. 169: 2875-2885.
18. Weiss, W. R., K. J. Ishii, R. C. Hedstrom, M. Sedegah, M. Ichino, K. Barnhart, D. M. Klinman, and S. L. Hoffman. 1998. A plasmid encoding murine granulocyte-macrophage colony-stimulating factor increases protection conferred by a malaria DNA vaccine. J. Immunol. 161: 2325-2332.
19. Siddiqui, A. A., T. Phillips, H. Charest, R. B. Podesta, M. L. Quinlin, J. R. Pinkston, J. D. Lloyd, M. Paz, R. M. Villalovos, and J. Pompa. 2003. Induction of protective immunity against Schistosoma mansoni via DNA priming and boosting with the large subunit of calpain (Sm-p80): adjuvant effects of granulocyte-macrophage colony-stimulating factor and interleukin-4. Infect. Immun. 71: 3844-3851.
20. Parker, J. N., L. A. Pfister, D. Quenelle, G. Y. Gillespie, J. M. Markert, E. R. Kern, and R. J. Whitley. 2006. Genetically engineered herpes simplex viruses that express IL-12 or GM-CSF as vaccine candidates. Vaccine 24: 1644-1652.
21. Qiu, J. T., T. C. Chang, C. T. Lin, Y. M. Chen, F. Q. Li, Y. K. Soong, and C. H. Lai. 2007. Novel codon-optimized GM-CSF gene as an adjuvant to enhance the immunity of a DNA vaccine against HIV-1 Gag. Vaccine 25: 253-263.
22. Park, L. S., D. Friend, S. Gillis, and D. L. Urdal. 1986. Characterization of the cell surface receptor for granulocyte-macrophage colony-stimulating factor. J. Biol. Chem. 261: 4177-4183.
23. Wada, H., Y. Noguchi, M. W. Marino, A. R. Dunn, and L. J. Old. 1997. T cell functions in granulocyte/macrophage colony-stimulating factor deficient mice. Proc. Natl. Acad. Sci. USA 94: 12557-12561.
24. O'Donnell, M. A., A. Aldovini, R. B. Duda, H. Yang, A. Szilvasi, R. A. Young, and W. C. DeWolf. 1994. Recombinant Mycobacterium bovis BCG secreting functional interleukin-2 enhances γ interferon production by splenocytes. Infect. Immun. 62: 2508-2514.
25. Murray, P. J., A. Aldovini, and R. A. Young. 1996. Manipulation and potentiation of anti-mycobacterial immunity using recombinant bacille Calmette-Guerin strains that secrete cytokines. Proc. Natl. Acad. Sci. USA 93: 934-939.
26. Luo, Y., H. Yamada, X. Chen, A. A. Ryan, D. P. Evanoff, J. A. Triccas, and M. A. O'Donnell. 2004. Recombinant Mycobacterium bovis bacillus Calmette-Guerin (BCG) expressing mouse IL-18 augments Th1 immunity and macrophage cytotoxicity. Clin. Exp. Immunol. 137: 24-34.
27. Ryan, A. A., J. M. Spratt, W. J. Britton, and J. A. Triccas. 2007. Secretion of functional monocyte chemotactic protein-3 by recombinant Mycobacterium bovis BCG attenuates vaccine virulence and maintains protective efficacy against M. tuberculosis infection. Infect. Immun. 75: 523-526.
28. Spratt, J., A. A. Ryan, W. J. Britton, and J. A. Triccas. 2005. Epitope-tagging vectors for the expression and detection of recombinant proteins in mycobacteria. Plasmid 53: 269-273.
29. Palendira, U., A. Kamath, C. Feng, E. Martin, P. Chaplin, J. Triccas, and W. Britton. 2002. Co-expression of interleukin-12 chains by a self splicing vector increases the protective cellular immune response of DNA and BCG vaccines against Mycobacterium tuberculosis. Infect. Immun. 70: 1949-1956.
30. Wozniak, T. M., A. A. Ryan, J. A. Triccas, and W. J. Britton. 2006. Plasmid interleukin-23 (IL-23), but not plasmid IL-27, enhances the protective efficacy of a DNA vaccine against Mycobacterium tuberculosis infection. Infect. Immun. 74: 557-565.
31. Fulcher, D. A., A. B. Lyons, S. L. Korn, M. C. Cook, C. Koleda, C. Parish, B. Fazekas de St. Groth, and A. Basten. 1996. The fate of self-reactive B cells depends primarily on the degree of antigen receptor engagement and availability of T cell help. J. Exp. Med. 183: 2313-2328.
32. Fazekas de St. Groth, B., A. L. Smith, W. P. Koh, L. Girgis, M. C. Cook, and P. Bertolino. 1999. Carboxyfluorescein diacetate succinimidyl ester and the virgin lymphocyte: a marriage made in heaven. Immunol. Cell Biol. 77: 530-538.
33. + T cells in low-dose irradiated mice: role of T cell antigen receptor and IL-7 receptor signals. J. Immunol. 177: 8320-8330.
34. Salomon, B., J. L. Cohen, C. Masurier, and D. Klatzmann. 1998. Three populations of mouse lymph node dendritic cells with different origins and dynamics. J. Immunol. 160: 708-717.
35. Villadangos, J. A., and W. R. Heath. 2005. Life cycle, migration and antigen presenting functions of spleen and lymph node dendritic cells: limitations of the Langerhans cells paradigm. Semin. Immunol. 17: 262-272.
36. Chabalgoity, J. A., A. Baz, A. Rial, and S. Grille. 2007. The relevance of cytokines for development of protective immunity and rational design of vaccines. Cytokine Growth Factor Rev. 18: 195-207.
37. Vremec, D., G. J. Lieschke, A. R. Dunn, L. Robb, D. Metcalf, and K. Shortman. 1997. The influence of granulocyte/macrophage colony-stimulating factor on dendritic cell levels in mouse lymphoid organs. Eur. J. Immunol. 27: 40-44.
38. Luo, Y., X. Chen, and M. A. O'Donnell. 2007. Mycobacterium bovis bacillus Calmette-Guerin (BCG) induces human CC- and CXC-chemokines in vitro and in vivo. Clin. Exp. Immunol. 147: 370-378.
39. Li, B., M. J. Van Roey, and K. Jooss. 2007. Recombinant IL-7 enhances the potency of GM-CSF-secreting tumor cell immunotherapy. Clin. Immunol. 123: 155-165
40. Dessureault, S., D. Noyes, D. Lee, M. Dunn, W. Janssen, A. Cantor, E. Sotomayor, J. Messina, and S. J. Antonia. 2007. A phase-I trial using a universal GM-CSF-producing and CD40L-expressing bystander cell line (GM.CD40L) in the formulation of autologous tumor cell-based vaccines for cancer patients with stage IV disease. Ann. Surg. Oncol. 14: 869-884.
41. Burke, B., A. Pridmore, N. Harraghy, A. Collick, J. Brown, and T. Mitchell. 2004. Transgenic mice showing inflammation-inducible overexpression of granulocyte macrophage colony-stimulating factor. Clin. Diagn. Lab. Immunol. 11: 588-598.
42. + T lymphocyte responses. J. Immunol. 172: 3725-3735.
43. Gonzalez-Juarrero, M., J. M. Hattle, A. Izzo, A. P. Junqueira-Kipnis, T. S. Shim, B. C. Trapnell, A. M. Cooper, and I. M. Orme. 2005. Disruption of granulocyte macrophage-colony stimulating factor production in the lungs severely affects the ability of mice to control Mycobacterium tuberculosis infection. J. Leukocyte Biol. 77: 914-922.
44. Chang, D. Z., W. Lomazow, C. Joy Somberg, R. Stan, and M. A. Perales. 2004. Granulocyte-macrophage colony stimulating factor: an adjuvant for cancer vaccines. Hematology 9: 207-215.
45. Pedral-Sampaio, D. B., E. M. Netto, C. Brites, A. C. Bandeira, C. Guerra, M. G. Barberin, and R. Badaro. 2003. Use of Rhu-GM-CSF in pulmonary tuberculosis patients: results of a randomized clinical trial. Braz. J. Infect. Dis. 7: 245-252.
46. Kletter, Y., I. Bleiberg, D. W. Golde, and I. Fabian. 1989. Antibody to Mol abrogates the increase in neutrophil phagocytosis and degranulation induced by granulocyte-macrophage colony-stimulating factor. Eur. J. Haematol. 43: 389-396.
47. Abadie, V., E. Badell, P. Douillard, D. Ensergueix, P. J. Leenen, M. Tanguy, L. Fiette, S. Saeland, B. Gicquel, and N. Winter. 2005. Neutrophils rapidly migrate via lymphatics after Mycobacterium bovis BCG intradermal vaccination and shuttle live bacilli to the draining lymph nodes. Blood 106: 1843-1850.
48. Lu, H., Z. Xing, and R. C. Brunham. 2002. GM-CSF transgene-based adjuvant allows the establishment of protective mucosal immunity following vaccination with inactivated Chlamydia trachomatis. J. Immunol. 169: 6324-6331.
49. Miyajima, A., A. L. Mui, T. Ogorochi, and K. Sakamaki. 1993. Receptors for granulocyte-macrophage colony-stimulating factor, interleukin-3, and interleukin-5. Blood 82: 1960-1974.